고객 맞춤형 상담과 미래지향적인 행보가 저희의 성공 기반이 되었습니다. 지식재산권법의 전분야에서 폭넓은 업무 경험을 쌓아온 최고의 전문 변리사와 변호사 팀을 신뢰해 보십시오.
사업 분야에 대해 더 알아보기
In its ruling on EP 3 536 712 B1, the Düsseldorf Local Division of the UPC for the first time outlined crucial criteria for patent infringement based on second medical use cl...
Continue reading
Royalty Pharma has acquired a royalty interest in Amgen's Imdelltra, an innovative BiTE antibody for the treatment of small cell lung cancer, from BeOne Medicines for an upfro...
Continue reading
We are delightet that IAM has recognized eight of our partners as Strategy 300 Global Leaders 2025:
Continue reading
For more awards and information, click here.
